MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Tax Rate of 0.9% for Q1 2026, down 52.0% year-over-year from 1.88% in Q1 2025, and down 127.88% quarter-over-quarter from 0.4% in Q4 2025.
Powered by 
Analysis
MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Tax Rate history runs 6 years deep, the most recent figure standing at 0.9% for Q1 2026.
- In Q1 2026, Tax Rate fell 52.0% year-over-year to 0.9%; the TTM figure through Mar 2026 stood at 0.42% (down 17.0% YoY), while the FY2025 annual figure was 0.27%, down 3.0% from the prior year.
- Tax Rate for Q1 2026 stood at 0.9%, down from 0.4% in the prior quarter.
- The five-year high for Tax Rate was 0.05% in Q1 2022, with the low at 0.9% in Q1 2026.
- The 5-year median for Tax Rate is 0.17% (2025), against an average of 0.26%.
- The sharpest annual moves came in 2024 and 2026: Tax Rate jumped 47 bps in 2024, then sank 52 bps in 2026.
- MoonLake Immunotherapeutics' Tax Rate stood at 0.07% in 2022, then plunged by 737 bps to 0.56% in 2023, then soared by 84 bps to 0.09% in 2024, then tumbled by 347 bps to 0.4% in 2025, then tumbled by 128 bps to 0.9% in 2026.
- Business Quant data shows MLTX's Tax Rate at 0.9% in Q1 2026, 0.4% in Q4 2025, and 0.16% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -16.71% |
| 10 | MoonLake Immunotherapeutics | 1.10 Bn | 566.53 Mn | - | -0.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.15% |
| Mar 31, 2026 | -0.90% |
| Dec 31, 2025 | -0.40% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.17% |
| Mar 31, 2025 | -0.38% |
| Dec 31, 2024 | -0.09% |
| Sep 30, 2024 | -0.26% |
| Jun 30, 2024 | -0.32% |
| Mar 31, 2024 | -0.50% |
| Dec 31, 2023 | -0.56% |
| Sep 30, 2023 | -0.25% |
| Jun 30, 2023 | -0.08% |
| Mar 31, 2023 | -0.09% |
| Dec 31, 2022 | -0.07% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | -0.05% |
| Mar 31, 2022 | -0.05% |
| Dec 31, 2021 | -0.01% |